Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

First PET Imaging Studies With 63 Zn-Zinc Citrate in Healthy Human Participants and Patients With Alzheimer Disease

Journal Article · · Molecular Imaging
 [1];  [2];  [2];  [2];  [3];  [2];  [2];  [2];  [2];  [2];  [4];  [4];  [2]
  1. Mayo Clinic, Rochester, MN (United States). Dept. of Radiology; Mayo Clinic Rochester
  2. Mayo Clinic, Rochester, MN (United States). Dept. of Radiology
  3. Mayo Clinic, Rochester, MN (United States). Dept. of Health Sciences Research
  4. Mayo Clinic, Rochester, MN (United States). Dept. of Neurology
Abnormalities in zinc homeostasis are indicated in many human diseases, including Alzheimer disease (AD). 63Zn-zinc citrate was developed as a positron emission tomography (PET) imaging probe of zinc transport and used in a first-in-human study in 6 healthy elderly individuals and 6 patients with clinically confirmed AD. A dynamic PET imaging of the brain was performed for 30 minutes following intravenous administration of 63Zn-zinc citrate (~330 MBq). Subsequently, body PET images were acquired. Urine and venous blood were analyzed to give information on urinary excretion and pharmacokinetics. Regional cerebral 63Zn clearances were compared with 11C-Pittsburgh Compound B (11C-PiB) and 18F-fluorodeoxyglucose (18F-FDG) imaging data. 63Zn-zinc citrate was well tolerated in human participants with no adverse events monitored. Tissues of highest uptake were liver, pancreas, and kidney, with moderate uptake being seen in intestines, prostate (in males), thyroid, spleen, stomach, pituitary, and salivary glands. Moderate brain uptake was observed, and regional dependencies were observed in 63Zn clearance kinetics in relationship with regions of high amyloid-β plaque burden (11C-PiB) and 18F-FDG hypometabolism. In conclusion, zinc transport was successfully imaged in human participants using the PET probe 63Zn-zinc citrate. Primary sites of uptake in the digestive system accent the role of zinc in gastrointestinal function. Preliminary information on zinc kinetics in patients with AD evidenced regional differences in clearance rates in correspondence with regional amyloid-β pathology, warranting further imaging studies of zinc homeostasis in patients with AD.
Research Organization:
Mayo Clinic, Rochester, MN (United States)
Sponsoring Organization:
AVID Radiopharmaceuticals, Philadelphia, PA (United States); Elsie and Marvin Dekelboum Family Foundation; GE Healthcare, Little Chalfont (United Kingdom); National Institute on Aging; Siemens Molecular Imaging, Inc, Knoxville, TN (United States); USDOE Office of Science (SC), Biological and Environmental Research (BER) (SC-23). Biological Systems Science Division
Grant/Contract Number:
SC0008947
OSTI ID:
1423938
Journal Information:
Molecular Imaging, Journal Name: Molecular Imaging Journal Issue: 1-10 Vol. 15; ISSN 1536-0121
Publisher:
SAGECopyright Statement
Country of Publication:
United States
Language:
English

References (40)

Zinc homeostasis in the metabolic syndrome and diabetes journal February 2013
Zinc and insulin in pancreatic beta-cells journal August 2013
ZIP14 Zinc Transporter Downregulation and Zinc Depletion in the Development and Progression of Hepatocellular Cancer journal March 2011
Abnormal zinc metabolism in type II diabetes mellitus journal August 1983
Alzheimer's disease diagnosis in individual subjects using structural MR images: Validation studies journal February 2008
Therapeutics for Alzheimer’s disease based on the metal hypothesis journal July 2008
Functional characterization of purified zinc transporter from renal brush border membrane of rat journal December 2000
Mo2111 Vitamin and Mineral Status Pre and Post Treatment in Patients With Inflammatory Bowel Disease journal May 2013
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial journal September 2008
Zinc and zinc transporters in prostate carcinogenesis journal March 2013
Urine and Serum Zinc Abnormalities in Disease of the Liver journal October 1965
Biochemistry of Amyloid  -Protein and Amyloid Deposits in Alzheimer Disease journal February 2012
Rapid induction of Alzheimer A beta amyloid formation by zinc journal September 1994
Zinc Competition among the Intestinal Microbiota journal July 2012
Plasma and urinary zinc in patients with malabsorption syndromes or hepatic cirrhosis journal December 1973
Pancreatic Secretion of Zinc and Copper in Normal Subjects and in Patients with Chronic Pancreatitis journal January 1991
Zinc Supplementation in Public Health journal January 2013
Elevated cortical zinc in Alzheimer disease journal July 2006
The Role of Zinc in Life: A Review journal January 2006
Preparation and Preliminary Evaluation of 63Zn-Zinc Citrate as a Novel PET Imaging Biomarker for Zinc journal July 2014
Cellular Mechanisms of Zinc Dysregulation: A Perspective on Zinc Homeostasis as an Etiological Factor in the Development and Progression of Breast Cancer journal July 2012
Decreased zinc and downregulation of ZIP3 zinc uptake transporter in the development of pancreatic adenocarcinoma journal August 2011
Status of Essential Trace Minerals and Oxidative Stress in Viral Hepatitis C Patients with Nonalcoholic Fatty Liver Disease journal January 2013
Diet, nutrient deficiency and chronic pancreatitis journal June 2013
Hepatic zinc content in patients with various stages of alcoholic liver disease and in patients with chronic active and chronic persistent hepatitis journal November 1988
Correspondence between in vivo 11C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques journal August 2012
Zinc and the aging brain journal December 2013
Abnormal zinc metabolism in type II diabetes mellitus journal June 1984
Functional characterization of purified zinc transporter from renal brush border membrane of rat journal December 2000
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial journal September 2008
Zinc Binding Directly Regulates Tau Toxicity Independent of Tau Hyperphosphorylation journal August 2014
PET Neuroimaging Studies of [ 18 F]CABS13 in a Double Transgenic Mouse Model of Alzheimer’s Disease and Nonhuman Primates journal March 2015
Vitamin and Mineral Status in Patients With Inflammatory Bowel Disease journal January 2013
Zinc supplementation restores plasma concentrations of zinc and thymulin in patients with Crohn's disease journal June 1993
Zinc Competition among the Intestinal Microbiota journal July 2012
Serum Zinc Concentrations in Two Cohorts of 153 Healthy Subjects and 100 Cirrhotic Patients from Mexico City journal January 1995
The Zinc Dyshomeostasis Hypothesis of Alzheimer's Disease journal March 2012
The Role of Zinc in Life: A Review journal January 2006
Metabolic profiling distinguishes three subtypes of Alzheimer's disease journal August 2015
Comparison of 18F-FDG and PiB PET in Cognitive Impairment journal May 2009

Cited By (4)

A Novel Microtubule-Tau Association Enhancer and Neuroprotective Drug Candidate: Ac-SKIP journal October 2019
Across the spectrum: integrating multidimensional metal analytics for in situ metallomic imaging journal January 2019
Production of radiometals in liquid targets journal January 2020
Zinc Chloride Exposure Inhibits Brain Acetylcholine Levels, Produces Neurotoxic Signatures, and Diminishes Memory and Motor Activities in Adult Zebrafish journal October 2018

Similar Records

Tau covariance patterns in Alzheimer's disease patients match intrinsic connectivity networks in the healthy brain
Journal Article · Wed May 01 20:00:00 EDT 2019 · NeuroImage: Clinical · OSTI ID:1604668

Tau PET and multimodal brain imaging in patients at risk for chronic traumatic encephalopathy
Journal Article · Wed Oct 16 20:00:00 EDT 2019 · NeuroImage: Clinical · OSTI ID:1599790

Multimodal Imaging of Alzheimer Pathophysiology in the Brain's Default Mode Network
Journal Article · Fri Dec 31 19:00:00 EST 2010 · International Journal of Alzheimer's Disease · OSTI ID:1198463